On August 20, 2026, DFZQ sold 39.12 million shares of CSPC PHARMA (01093) at an average of HKD 9.7533 per share, involving about HKD 381.59 million.
Prior to the disposal, DFZQ's long position in CSPC PHARMA was 607.70 million shares, representing 5.27%; following the disposal, the holding changed to 568.58 million shares, with the long position ratio falling to 4.93%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.